Product
Anti-PD-1 antibody
Aliases
anti-PD-1, anti-PD-1 antibody, anti-PD-1 antibody injection
Name
anti-PD-1
2 clinical trials
1 drug
2 indications
Indication
Advanced Malignant TumorsIndication
Advanced Solid TumorClinical trial
A Multicenter, Open Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBL-019 Monotherapy or Combination Anti-PD-1 Antibody in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2025-03-22
Clinical trial
A Phase 1/2 Study to Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TU2218, an Oral TGFβR Inhibitor, Administered Alone and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-06-30